BACTROBAN Nasal ong nasal tb 3 g
7680523610288
CH-52361
R01AX06
12.02.51
1 / 3
google
Details
- Product number
- 5236101
- CPT
- -
- Packaging group
- 3
- Unit
- g
- Composition
- mupirocinum 20 mg ut mupirocinum calcicum, vaselinum album, glyceroli mono/di/triadipas/alcanoas(C8,C10)/isostearas ad unguentum pro 1 g.
Articles (1)
Bactroban Nasal, Nasensalbe
Nasensalbe
3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 52361
- Drug name
- Bactroban Nasal, Nasensalbe
- Galenic form
- NASA
- ATC Code
- R01AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/01/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 12.02.51
- Domain
- Human medicine
Packaging details
- Description (FR)
- BACTROBAN Nasal ong nasal tb 3 g
- Description (DE)
- BACTROBAN Nasal Nasensalbe Tb 3 g
- Market launch
- 28/01/1994
- Narcotic (BTM)
- No